Benitec Biopharma Limited Shareholders Equity (Tangible)

Shareholders Equity (Tangible) of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Tangible) growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity (Tangible) for the quarter ending June 30, 2022 was $2.88 Million (a -61.68% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Tangible) decreased by -81.38%
  • Annual Shareholders Equity (Tangible) for 2022 was $2.88 Million (a -85.6% decrease from previous year)
  • Annual Shareholders Equity (Tangible) for 2021 was $20 Million (a 95.45% increase from previous year)
  • Annual Shareholders Equity (Tangible) for 2020 was $10.2 Million (a -38.3% decrease from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Tangible) of Benitec Biopharma Limited

Most recent Shareholders Equity (Tangible)of BNTC including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Tangible) of Benitec Biopharma Limited

Benitec Biopharma Limited Shareholders Equity (Tangible) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $2.88 $7.52 $2.88
2021 $10.84 $15.48 $20.01 $10.93 $20.01
2020 $14.63 $7.74 $10.24 $10.24
2019 $14.87 $16.59
2018 $14.53
2017 $14.83 $16.21
2016 $14.96 $13.72 $17.94 $13.72
2015 $19.65 $19.99 $19.99
2014 $25.35 $30.8 $30.8
2013 $0.65 $0.66

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology